Showing results (141-150 of 171) with videos related to
Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|September 1, 1982
Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United StatesR L Stiller, J E Bennett, H J Scholer, et al.The Journal of Infectious Diseases|June 1, 1983
Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis modelR L Stiller, J E Bennett, H J Scholer, et al.The Journal of Biological Chemistry|October 25, 1992
Flow cytometric kinetic measurements of neutrophil phospholipase A activationT Meshulam, H Herscovitz, D Casavant, et al.The Journal of Experimental Medicine|August 1, 1996
Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformansS D Salas, J E Bennett, K J Kwon-Chung, et al.Medical Mycology|February 13, 1999
Biosafety considerations in handling medically important fungiA A Padhye, J E Bennett, M R McGinnis, et al.Infection and Immunity|August 1, 1987
Urease inhibition by EDTA in the two varieties of Cryptococcus neoformansK J Kwon-Chung, B L Wickes, J L Booth, et al.Gastroenterology|July 1, 1984
Esophageal cryptococcosis in a patient with the hyperimmunoglobulin E-recurrent infection (Job's) syndromeD H Jacobs, A M Macher, R Handler, et al.Experimental Brain Research|November 18, 2000
Bimanual co-ordination in Huntington's diseaseK A Johnson, J E Bennett, N Georgiou, et al.Journal of Clinical Pathology|October 1, 1986
Assessment of new radioimmunoassay kit for determining urinary albumin at low concentrations: comparison with radial immunodiffusionG F Watts, J D Albano, J E Bennett, et al.Reviews of Infectious Diseases|July 1, 1980
Criteria for evaluation of therapeutic response to antifungal drugsW E Dismukes, J E Bennett, D J Drutz, et al.Pageof 18